Drugs / QDP-PSA-011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06798168 | — | periprosthetic joint infection | Ottawa Hospital Research Institute | Available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QDP-PSA-011 | “The treatment plan is to treat the patient with weekly intra-articular injections of a personalized phage therapy cocktail (QDP-PSA-011) for 3 consecutive weeks.” NCT06798168 ↗ |
| Modality | Other / unclassified | “personalized phage therapy cocktail (QDP-PSA-011)” NCT06798168 ↗ |